CD44 and breast carcinoma: For breast cancer, Al−Hajji et al. (2003) [10] showed that cells which overexpress the transmembrane glycoprotein CD44 and underexpress the cell membrane sialoglycoprotein CD24 (CD44high/CD24−/low), possess tumorigenic properties.